BeOne Medicines Ltd. Insider Trading Activity
Every SEC Form 4 insider transaction reported for BeOne Medicines Ltd. (ONC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ONC insiders buying or selling?
In the last 12 months, BeOne Medicines Ltd. insiders reported 0 open-market purchases ($0) and 49 sales ($345.3M) — net selling of $345.3M. Since January 2018, Trabud has recorded 297 Form 4 filings for ONC: 3 buys ($877.9M) and 294 sells ($6.5B).
Source: SEC EDGAR Form 4
What stands out
- No BeOne Medicines Ltd. insider made an open-market purchase in the last 12 months; the 49 reported open-market sales totaled $345.3M.
Key Statistics (January 2018 – Oct 15, 2026)
Total Form 4 filings
297
SEC EDGAR
Insider filers
21
Insider buys (3)
$877.9M
Insider sells (294)
$6.5B
Insider sentiment
Net sellingNet insider flow of $5.6B in net selling since January 2018, and $345.3M in net selling over the last 12 months.
Recent ONC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Xiaodong Wang | Director | Sale | 31.0K | $350.99 | $10.9M | SEC ↗ |
| Oct 2, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 1.1K | $375.00 | $418.1K | SEC ↗ |
| Sep 30, 2026 | Xiaodong Wang | Director | Sale | 31.0K | $364.79 | $11.3M | SEC ↗ |
| Sep 10, 2026 | Xiaodong Wang | Director | Sale | 38.3K | $349.10 | $13.4M | SEC ↗ |
| Sep 3, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 132 | $355.86 | $47.0K | SEC ↗ |
| Aug 27, 2026 | Xiaobin Wu | President and COO | Sale | 280 | $380.00 | $106.4K | SEC ↗ |
| Aug 14, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 2.7K | $360.00 | $959.8K | SEC ↗ |
| Aug 12, 2026 | John Oyler | Chief Executive Officer | Sale | 240.8K | $359.12 | $86.5M | SEC ↗ |
| Aug 5, 2026 | Aaron Rosenberg | Chief Financial Officer | Sale | 1.2K | $312.71 | $361.8K | SEC ↗ |
| Aug 3, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 1.0K | $323.69 | $337.9K | SEC ↗ |
| Jul 24, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 1.7K | $325.00 | $542.4K | SEC ↗ |
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 64.6K | $312.00 | $20.2M | SEC ↗ |
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 283.2K | $315.56 | $89.4M | SEC ↗ |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 145.9K | $305.95 | $44.6M | SEC ↗ |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 60.2K | $303.18 | $18.3M | SEC ↗ |
| Jun 25, 2026 | Xiaobin Wu | President and COO | Sale | 1.3K | $276.26 | $356.9K | SEC ↗ |
| Jun 25, 2026 | John Oyler | Chief Executive Officer | Sale | 3.4K | $273.78 | $933.6K | SEC ↗ |
| Jun 25, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.1K | $276.74 | $295.6K | SEC ↗ |
| Jun 18, 2026 | Xiaobin Wu | President and COO | Sale | 1.4K | $266.76 | $362.0K | SEC ↗ |
| Jun 18, 2026 | John Oyler | Chief Executive Officer | Sale | 3.7K | $265.55 | $980.7K | SEC ↗ |
| Jun 18, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 590 | $265.98 | $156.9K | SEC ↗ |
| Jun 18, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.2K | $265.39 | $310.2K | SEC ↗ |
| Jun 15, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 169 | $257.20 | $43.5K | SEC ↗ |
| Jun 15, 2026 | Lai Wang | President, Global Head of R&D | Sale | 756 | $261.00 | $197.3K | SEC ↗ |
| Jun 15, 2026 | Aaron Rosenberg | Chief Financial Officer | Sale | 631 | $257.74 | $162.6K | SEC ↗ |
Showing the 25 most recent of 297 Form 4 filings for BeOne Medicines Ltd..
Most active ONC insiders
- John Oyler58 filings
- Jane Huang43 filings
- Xiaodong Wang41 filings
- Xiaobin Wu40 filings
- Chan Henry Lee26 filings
Ask anything about ONC insider activity
Use Trabud's AI agent to query BeOne Medicines Ltd.'s Form 4 history in plain English — "Show me ONC CEO purchases this year" or compare it against any other ticker.
Open the AI agentONC insider trading FAQ
Are BeOne Medicines Ltd. insiders buying or selling?
In the last 12 months, BeOne Medicines Ltd. insiders reported 0 open-market purchases ($0) and 49 sales ($345.3M) — net selling of $345.3M. Since January 2018, Trabud has recorded 297 Form 4 filings for ONC: 3 buys ($877.9M) and 294 sells ($6.5B). Over the full record that is net selling of $5.6B.
How many insiders trade ONC stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BeOne Medicines Ltd.. The most recent filing was accepted on Oct 15, 2026.
Where does Trabud get ONC insider trading data?
All ONC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.